ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 164 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $691 | -86.8% | 34,798 | -88.6% | 0.01% | -86.0% |
Q1 2023 | $5,243 | -99.1% | 306,062 | +718.3% | 0.04% | +437.5% |
Q3 2022 | $597,000 | +145.7% | 37,402 | +111.6% | 0.01% | +166.7% |
Q2 2022 | $243,000 | -25.2% | 17,675 | -13.8% | 0.00% | -25.0% |
Q1 2022 | $325,000 | -83.6% | 20,494 | -43.2% | 0.00% | -78.9% |
Q4 2020 | $1,979,000 | +192.8% | 36,085 | +22.0% | 0.02% | +46.2% |
Q3 2020 | $676,000 | -4.4% | 29,569 | -4.8% | 0.01% | 0.0% |
Q4 2019 | $707,000 | +381.0% | 31,054 | +146.5% | 0.01% | +160.0% |
Q3 2019 | $147,000 | – | 12,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |